Original Research
Accepted on 23 Apr 2025
SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN PATIENTS WITH IMMUNE MEDIATED DISEASES IN CLINICAL REMISSION
in Gastroenterology
Original Research
Accepted on 23 Apr 2025
in Gastroenterology
Case Report
Accepted on 23 Apr 2025
in General Cardiovascular Medicine
Original Research
Accepted on 23 Apr 2025
in Structural Materials
Original Research
Accepted on 23 Apr 2025
in Agricultural and Food Economics
Editorial
Accepted on 23 Apr 2025
in Connected Health
Perspective
Accepted on 23 Apr 2025
in Sports Management, Marketing, and Economics
Original Research
Accepted on 23 Apr 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 23 Apr 2025
in Animal Behavior and Welfare
Original Research
Accepted on 23 Apr 2025
in Nutritional Epidemiology
Original Research
Accepted on 23 Apr 2025
in Elasmobranch Science
Original Research
Accepted on 23 Apr 2025
in T Cell Biology
Review
Accepted on 23 Apr 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 23 Apr 2025
in Nutrition and Metabolism
Original Research
Accepted on 23 Apr 2025
in Food Chemistry
Original Research
Accepted on 23 Apr 2025
in Nutritional Immunology
Systematic Review
Accepted on 23 Apr 2025
in Sport and Exercise Nutrition